Stock comparison
Jazz Pharmaceuticals
JAZZ$15.45BHealthcare Market cap, Sector
Roche
RO.SW$298.95BHealthcare Market cap, Sector
Roche
JAZZ 07 RO.SW
Based on the combined fit scores from all four strategies. The breakdown by strategy is below.
Fit scores by strategy
Side-by-side metrics
| Metric | JAZZ | RO.SW |
|---|---|---|
| Market cap | $15.45B | $298.95B Winner |
| P/E (TTM) | 501.8x | 20.5x Winner |
| EV/EBIT | 82.8x | 15.9x Winner |
| ROIC (TTM) |
Where each one wins
The metrics with the widest gap between the two, biggest differences first.
JAZZ leads on
- Revenue CAGR 5y8.37%vs -1.26%+115%
- Gross margin84.12%vs 73.73%+12%
RO.SW leads on
- ROIC (TTM)23.24%vs -0.62%+103%
- Net margin20.33%vs 0.66%+97%
More like JAZZ
More like RO.SW
Related on invest-like
For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.